Trial Profile
An Open Label Multi-center Study of Augmentation Cystoplasty Using an Autologous Neo-Bladder Construct in Subjects With Non-Neurogenic Overactive Bladder and Urge Predominant Incontinence
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 13 Jun 2018
Price :
$35
*
At a glance
- Drugs Autologous cultured urological tissue cells (Primary)
- Indications Overactive bladder
- Focus Adverse reactions; Therapeutic Use
- Sponsors Tengion
- 20 Jun 2014 New trial record